Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$70,957,950
+$6,972,610 QoQ
Shares Held
281,982
-4.2% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#307
of 4,153 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PINEBRIDGE INVESTMENTS LLC holds $399,304,962 across 8 Drug Manufacturers - General names. ABBV ranks #3 (17.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
101,506 | $121,749,351 | |
| 2 | JNJ |
Johnson & Johnson
|
326,298 | $82,869,903 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
281,982 | $70,957,950 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
827,889 | $47,702,964 | |
| 5 | AMGN |
Amgen Inc
|
73,641 | $26,666,878 | |
| 6 | PFE |
Pfizer Inc
|
1,070,303 | $25,772,896 | |
| 7 | MRK |
Merck & Co., Inc.
|
158,976 | $20,428,416 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
24,985 | $3,156,604 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,957,950 | 281,982 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $63,985,340 | 294,199 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $32,571,934 | 142,553 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||